Protection versus pathology in aviremic and high viral load HIV-2 infection - The pivotal role of immune activation and T-cell kinetics

Journal of Infectious Diseases

Volumn 210, Issue 5, 2014, Pages 752-761

  Hegedus, Andrea ^a   Nyamweya, Samuel ^b   Zhang, Yan ^a   Govind, Sheila ^c   Aspinall, Richard ^c   Mashanova, Alla ^d   Jansen, Vincent A A ^d   Whittle, Hilton ^b   Jaye, Assan ^b   Flanagan, Katie L ^b,e   Macallan, Derek C ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c CRANFIELD UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

Author keywords

CD4; CD8; HIV pathogenesis; HIV 1; HIV 2; Immune activation; Immune memory; T cell

Indexed keywords

CD38 ANTIGEN; DEUTERIUM; GLUCOSE; HLA DR ANTIGEN; KI 67 ANTIGEN;

ADULT; AFRICA; ANTIGEN EXPRESSION; ARTICLE; ASYMPTOMATIC DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDEMIC DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNOREACTIVITY; IN VIVO STUDY; INFECTION PREVENTION; LYMPHOCYTE COUNT; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS PATHOGENESIS;

CD4; CD8; HIV PATHOGENESIS; HIV-1; HIV-2; IMMUNE ACTIVATION; IMMUNE MEMORY; T-CELL;

ADULT; FEMALE; GAMBIA; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-2; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; VIRAL LOAD; YOUNG ADULT;

EID: 84907424123     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu165     Document Type: Article

References (50)

1. Rowland-Jones SL, Whittle HC. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? Nat Immunol 2007; 8:329-31.
2. Nyamweya S, Hegedus A, Jaye A, Rowland-Jones S, Flanagan KL, Macallan DC. Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis. Rev Med Virol 2013; 23:221-40.
3. Gottlieb GS, Sow PS, Hawes SE, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002; 185:905-14.
4. van der Loeff MF, Larke N, Kaye S, et al. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology 2010; 7:46.
5. Berry N, Ariyoshi K, Jaffar S, et al. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol 1998; 1:457-68.
6. Lewin SR, Rouzioux C. HIV cure and eradication: how will we get from the laboratory to effective clinical trials? AIDS 2011; 25:885-97.
7. Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol 2000; 74:9594-600.
8. Soriano V, Gomes P, Heneine W, et al. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol 2000; 61:111-6.
9. Hansmann A, Schim van der Loeff MF, Kaye S, et al. Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV- 2-infected women in a community-based cohort in The Gambia. J Acquir Immune Defic Syndr 2005; 38:335-41.
10. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993; 7:1569-79.
11. Duvall MG, Precopio ML, Ambrozak DA, et al. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol 2008; 38:350-63.
12. Lopes AR, Jaye A, Dorrell L, et al. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J Immunol 2003; 171:307-16.
13. Leligdowicz A, Yindom LM, Onyango C, et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 2007; 117:3067-74.
14. de Silva TI, Peng Y, Leligdowicz A, et al. Correlates of T-cell-mediated viral control and phenotype of CD8+ T cells in HIV-2, a naturally contained human retroviral infection. Blood 2013; 121:4330-9.
15. Esbjornsson J, Mansson F, Kvist A, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med 2012; 367:224-32.
16. van Tienen C, Schim van der LM, Whittle H. Effect of HIV-2 infection on HIV-1 disease progression. N Engl J Med 2012; 367:1961-3.
17. Prince PD, Matser A, van Tienen C, Whittle HC, Schim van der Loeff MF. Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and metaanalysis. AIDS 2014; 28:549-58.
18. Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, de Boer RJ, Borghans JA. Immune activation and collateral damage in AIDS pathogenesis. Front Immunol 2013; 4:298.
19. Hanson A, Sarr AD, Shea A, et al. Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection. AIDS Res Hum Retroviruses 2005; 21: 791-8.
20. Leligdowicz A, Feldmann J, Jaye A, et al. Direct relationship between virus load and systemic immune activation in HIV-2 infection. J Infect Dis 2010; 201:114-22.
21. Nyamweya S, Townend J, Zaman A, et al. Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections? PLOS One 2012; 7: e44411.
22. Mohri H, Perelson AS, Tung K, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 2001; 194:1277-87.
23. Kovacs JA, Lempicki RA, Sidorov IA, et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 2001; 194:1731-41.
24. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5:83-9.
25. Zhang Y, De Lara C, Worth A, et al. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism. PLOS Pathog 2013; 9: e1003310.
26. Macallan DC, Asquith B, Irvine AJ, et al. Measurement and modeling of human T cell kinetics. Eur J Immunol 2003; 33:2316-26.
27. den Braber I, Mugwagwa T, Vrisekoop N, et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 2012; 36:288-97.
28. Macallan DC, Asquith B, Zhang Y, et al. Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose. Nat Protoc 2009; 4:1313-27.
29. Mitchell WA, Lang PO, Aspinall R. Tracing thymic output in older individuals. Clin Exp Immunol 2010; 161:497-503.
30. Westera L, Zhang Y, Tesselaar K, Borghans JA, Macallan DC. Quantitating lymphocyte homeostasis in vivo in humans using stable isotope tracers. Methods Mol Biol 2013; 979:107-31.
31. Ghattas H, Darboe BM, Wallace DL, Griffin GE, Prentice AM, Macallan DC. Measuring lymphocyte kinetics in tropical field settings. Trans R Soc Trop Med Hyg 2005; 99:675-85.
32. De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 11-color, 13- parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001; 7:245-8.
33. Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK. Measurement of cell proliferation by heavy water labeling. Nat Protoc 2007; 2:3045-57.
34. Asquith B, Debacq C, Macallan DC, Willems L, Bangham CR. Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol 2002; 23:596-601.
35. Hellerstein MK, Hoh RA, Hanley MB, et al. Subpopulations of longlived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 2003; 112:956-66.
36. Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLOS Pathog 2013; 9:e1003211.
37. Onyango CO, Leligdowicz A, Yokoyama M, et al. HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine 2010; 28 (Suppl 2):B60-7.:B60-B67.
38. Tendeiro R, Albuquerque AS, Foxall RB, et al. Preserved CD4 T-cell telomere length during long-lasting HIV-2 infection. AIDS 2013; 27: 289-92.
39. Nowroozalizadeh S, Mansson F, da Silva Z, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010; 201:1150-4.
40. Kaur A, Di MM, Barabasz A, et al. Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus. J Virol 2008; 82:1084-93.
41. Doitsh G, Galloway NL, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505:509-14.
42. Monroe KM, Yang Z, Johnson JR, et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2014; 343:428-32.
43. Macallan DC, Wallace DL, Irvine AJ, et al. Rapid turnover of T cells in acute infectious mononucleosis. Eur J Immunol 2003; 33:2655-65.
44. Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med (Berl) 2001; 79:631-40.
45. Gautier D, Beq S, Cortesao CS, Sousa AE, Cheynier R. Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection. J Virol 2007; 81:12685-8.
46. Nokta MA, Li XD, Al-Harthi L, et al. Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load. AIDS 2002; 16:2119-27.
47. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-4.
48. D'Souza M, Fontenot AP, Mack DG, et al. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 2007; 179:1979-87.
49. Tendeiro R, Foxall RB, Baptista AP, et al. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia. AIDS 2012; 26:1065-71.
50. Gillespie GM, Pinheiro S, Sayeid-Al-Jamee M, et al. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur J Immunol 2005; 35:1445-53.